Description
The Texas Department of State Health Services (DSHS) is seeking bids for the purchase of 4 MiSeq i100 Plus sequencing instruments from Illumina. The instruments will be used for next-generation sequencing of genetic material from clinical and environmental samples. Bidders must submit a comprehensive response, including all required information and documentation, to be considered for award. The contract term is not specified, but the anticipated contract start date is May 21, 2026.
• The MiSeq i100 Plus sequencing instruments will be used for surveillance, variant detection, outbreak detection, and identifying mutations of interest.
• Bidders must submit adequate literature with their bid to facilitate item evaluation.
• All products must conform to the stated minimum specifications.
• The estimated historical spend for similar goods or services is $411,399.68.
• The contract will be awarded based on the best value for the state.